Hi! I’m Chris Gibson, Ph.D., the co-founder of Recursion, where I spent more than a decade as CEO building the world’s leading TechBio company—scaling it from a grad-school thesis to a multibillion-dollar, global, publicly-traded company with more than $500M in revenue and multiple clinical-stage assets. As I transition to co-founder and Chairman of Recursion, I am considering a limited number of seats for board service of publicly-traded companies, strategic advisory, and high-impact consulting. I partner with founders, boards, and R&D leaders on platform strategy, AI-enabled discovery, organizational design, culture, alliances, and long-horizon mission stewardship. I’m also an active angel-investor, supporting more than 30 young founders that are going to redefine the biopharma industry.